22 results on '"A.R. Zlotta"'
Search Results
2. Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
3. SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy
4. Inverse probability treatment weighting comparison of radical cystectomy to trimodality therapy for cT2-cT4 muscle invasive bladder cancer
5. Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study
6. FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
7. Vol. 35, 1999
8. Prostatitis and Urethritis
9. 746 Molecular tumour grading of non muscle invasive bladder cancer based on whole transcriptome analysis
10. Subject Index Vol. 35, 1999
11. 423 Functional role of the kallikrein 6 region of the kallikrein locus in genetic predisposition for aggressive (Gleason ≥8) prostate cancer: Fine-mapping and methylation study in a Canadian cohort and the Swiss arm of the European Randomized Study for Prostate Cancer Screening
12. 422 TERT promoter methylation is a pan-cancer biomarker with prognostic significance in prostate cancer patients
13. 755 A five-gene DNA-methylation biomarker panel sensitively detects bladder cancer and discriminates between high-grade and low-grade disease in voided urine
14. Contributors
15. 852 Prostate biopsy trends in relation to U.S. Preventative Task for recommendations against routine PSA-based screening: A time-series analysis
16. 206 Fine-mapping of the Kallikrein region and its role in prostate cancer aggressiveness: Results from a Canadian cohort and the European Randomized Study for Prostate Cancer Screening
17. 890 Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men
18. Prevention of prostate cancer
19. 603 FGFR3 PROTEIN OVER-EXPRESSION IN THE ABSENCE OF A FGFR3 MUTATION IS NOT ASSOCIATED WITH FAVORABLE DISEASE CHARACTERISTICS IN BLADDER CANCER
20. 765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER
21. Transurethral nedle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia
22. Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.